إعلان
إعلان

CLPT

CLPT logo

ClearPoint Neuro, Inc. Common Stock

14.94
USD
برعاية
-0.38
-2.45%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

15.13

+0.20
+1.31%

تقارير أرباح CLPT

النسبة الإيجابية المفاجئة

CLPT تفوق 15 من 26 آخر التقديرات.

58%

التقرير التالي

بيانات التقرير القادم
٢٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$10.25M
/
-$0.20
التغير الضمني من Q3 25 (Revenue/ EPS)
+15.69%
/
-4.76%
التغير الضمني من Q4 24 (Revenue/ EPS)
+31.91%
/
--

ClearPoint Neuro, Inc. Common Stock earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, CLPT reported earnings of -0.21 USD per share (EPS) for Q3 25, missing the estimate of -0.20 USD, resulting in a -2.94% surprise. Revenue reached 8.86 مليون, compared to an expected 9.79 مليون, with a -9.51% difference. The market reacted with a -13.27% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -0.20 USD, with revenue projected to reach 10.25 مليون USD, implying an نقصان of -4.76% EPS, and زيادة of 15.69% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
٠٦ يناير ٢٠٢٦ إلى ربع سنوي2 26
تقدير
-$0.10
الفعلي
$0.00
مفاجئة
+100.00%
الأسئلة الشائعة
For Q3 2025, ClearPoint Neuro, Inc. Common Stock reported EPS of -$0.21, missing estimates by -2.94%, and revenue of $8.86M, -9.51% below expectations.
The stock price moved down -13.27%, changed from $18.23 before the earnings release to $15.81 the day after.
The next earning report is scheduled for ٢٤ فبراير ٢٠٢٦.
Based on 4 المحللين, ClearPoint Neuro, Inc. Common Stock is expected to report EPS of -$0.20 and revenue of $10.25M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان